Cargando…
Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma
Melanoma is known as an exceptionally aggressive and treatment-resistant human cancer. Although a great deal of progress has been made in the past decade, including the development of immunotherapy using immune checkpoint inhibitors and targeted therapy using BRAF, MEK or KIT inhibitors, treatment f...
Autores principales: | Zhou, Linli, Yang, Kun, Andl, Thomas, Wickett, R. Randall, Zhang, Yuhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504107/ https://www.ncbi.nlm.nih.gov/pubmed/26185533 http://dx.doi.org/10.7150/jca.10865 |
Ejemplares similares
-
Dermal fibroblasts induce cell cycle arrest and block epithelial–mesenchymal transition to inhibit the early stage melanoma development
por: Zhou, Linli, et al.
Publicado: (2016) -
The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts
por: Liu, Tianyi, et al.
Publicado: (2019) -
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
por: Liu, Tianyi, et al.
Publicado: (2019) -
Activation of β-Catenin Signaling in CD133-Positive Dermal Papilla Cells Drives Postnatal Hair Growth
por: Zhou, Linli, et al.
Publicado: (2016) -
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
por: Xio, Yao, et al.
Publicado: (2023)